OptiNose Competitors and Similar CompaniesClear all

OptiNose's competitors and similar companies include Avedro.
OptiNose
OptiNose
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
Avedro
Avedro
Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals.
Founding Date
Founding Date
2000
Founding Date
2002
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Morrisville, US HQ
Oslo, NO
Swindon, GB
Locations
Waltham, US HQ
Employees
Employees
2048% decrease
Employees
122

Financial

Revenue (est.)
Revenue (est.)
$78.2m (FY, 2024)
Revenue (est.)
$27.7m (FY, 2018)
Cost of goods
Cost of goods
$7.2m (FY, 2024)
Cost of goods
$10.9m (FY, 2018)
Gross profit
Gross profit
$71m (FY, 2024)
Gross profit
$16.8m (FY, 2018)
Net income
Net income
($21.5m) (FY, 2024)
Net income
($25.1m) (FY, 2018)

Operating

Patents (US)
Patents (US)
43 (Jun, 2017)
Patents (US)
15 (Mar, 2019)
Trademarks (US)
Trademarks (US)
3 (Jun, 2017)
Trademarks (US)
10 (Mar, 2019)

Funding

Total funding raised
Total funding raised
$ 120.5m
Total funding raised
$ 67.6m
For sources of this data, please see the company profile

View Company Profiles

Avedro
HQ
Waltham, US

Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals.

View company